Iron Deficiency Anemia in Pregnancy: Intravenous Iron Sucrose versus Oral Iron Sulfate

Shabera Arzoo, Shereen Yousof, Jahanara Rahman, S. Chowdhury
{"title":"Iron Deficiency Anemia in Pregnancy: Intravenous Iron Sucrose versus Oral Iron Sulfate","authors":"Shabera Arzoo, Shereen Yousof, Jahanara Rahman, S. Chowdhury","doi":"10.3329/bjog.v33i1.43541","DOIUrl":null,"url":null,"abstract":"Introduction: Injectable iron sucrose and oral ferrous sulfate both are used for the correction of anaemia in second and third trimester of pregnancy. But injectable iron is supposed to be more effective than oral iron, as it needs less time for correction of anaemia and efficacy is more. Oral iron is cost effective but more time consuming. The objective of the study was to compare the safety of intravenous iron sucrose complex in the treatment of iron deficiency anemia in third trimester of pregnancy. To compare the efficacy of intravenous iron with oral iron. Method: A randomised controlled trial was conducted in which pregnant women with iron deficiency were sequentially selected from the pregnant women attended antenatal clinic of OPD of Institute of Child and Maternal Health (ICMH) and assigned either to injectable or to oral ferrous sulfate by random number table. Each study patient was given the total calculated amount of injectable iron sucrose {Hb deficit (gm/l) × body weight (kg) × 0.24+ storage iron mg } in divided dose 200 mg in 200 ml normal saline intravenously over 1 hour every alternate day . Each patient of the control group was given ferrous sulfate 200mg orally three times a day for 4 weeks. Pregnant women follow up at 4 weeks and 8 weeks after get treatment by oral and injectable iron. During follow up monitored for adverse effects, clinical and laboratory response and haemoglobin percentage were observed. Result: There were 75 patients in injectable group and 75 patients in oral group. Injectable group achieved a significantly higher Hb level (11.49 ± 0.39) than oral group Hb level (10.39 ± 0.75) after 8 weeks of treatment. Injectable group showed no major side effects, only two patient had complains .One patient complain of epigastic pain and one patient complain of tachycardia while in oral group complain of nausea and vomiting, epigastic pain, constipation, allergic reaction was found in 42.0%, 39.3%,35.7% and 3.6% respectively. Conclusion: Iron sucrose complex appears to be a safe and effective in the treatment of iron deficiency anemia. Key word: Iron deficiency anemia in pregnancy, Injectable iron, oral iron. Bangladesh J Obstet Gynaecol, 2018; Vol. 33(1): 40-44","PeriodicalId":39936,"journal":{"name":"Bangladesh Journal of Obstetrics and Gynecology","volume":"33 1","pages":"40-44"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3329/bjog.v33i1.43541","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bangladesh Journal of Obstetrics and Gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3329/bjog.v33i1.43541","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Introduction: Injectable iron sucrose and oral ferrous sulfate both are used for the correction of anaemia in second and third trimester of pregnancy. But injectable iron is supposed to be more effective than oral iron, as it needs less time for correction of anaemia and efficacy is more. Oral iron is cost effective but more time consuming. The objective of the study was to compare the safety of intravenous iron sucrose complex in the treatment of iron deficiency anemia in third trimester of pregnancy. To compare the efficacy of intravenous iron with oral iron. Method: A randomised controlled trial was conducted in which pregnant women with iron deficiency were sequentially selected from the pregnant women attended antenatal clinic of OPD of Institute of Child and Maternal Health (ICMH) and assigned either to injectable or to oral ferrous sulfate by random number table. Each study patient was given the total calculated amount of injectable iron sucrose {Hb deficit (gm/l) × body weight (kg) × 0.24+ storage iron mg } in divided dose 200 mg in 200 ml normal saline intravenously over 1 hour every alternate day . Each patient of the control group was given ferrous sulfate 200mg orally three times a day for 4 weeks. Pregnant women follow up at 4 weeks and 8 weeks after get treatment by oral and injectable iron. During follow up monitored for adverse effects, clinical and laboratory response and haemoglobin percentage were observed. Result: There were 75 patients in injectable group and 75 patients in oral group. Injectable group achieved a significantly higher Hb level (11.49 ± 0.39) than oral group Hb level (10.39 ± 0.75) after 8 weeks of treatment. Injectable group showed no major side effects, only two patient had complains .One patient complain of epigastic pain and one patient complain of tachycardia while in oral group complain of nausea and vomiting, epigastic pain, constipation, allergic reaction was found in 42.0%, 39.3%,35.7% and 3.6% respectively. Conclusion: Iron sucrose complex appears to be a safe and effective in the treatment of iron deficiency anemia. Key word: Iron deficiency anemia in pregnancy, Injectable iron, oral iron. Bangladesh J Obstet Gynaecol, 2018; Vol. 33(1): 40-44
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
妊娠期缺铁性贫血:静脉注射蔗糖铁与口服硫酸铁
简介:注射用蔗糖铁和口服硫酸亚铁均用于治疗妊娠中晚期贫血。但注射铁被认为比口服铁更有效,因为它需要更少的时间来纠正贫血,疗效更高。口服铁具有成本效益,但更耗时。本研究的目的是比较静脉注射蔗糖铁复合物治疗妊娠晚期缺铁性贫血的安全性。比较静脉铁与口服铁的疗效。方法:采用随机对照试验,从妇幼保健研究所门诊的孕妇中依次选择缺铁孕妇,用随机数表将其分为注射或口服硫酸亚铁组。每名研究患者每隔一天1小时静脉注射200 ml生理盐水中的200 mg,分剂量给予总计算量的可注射蔗糖铁{Hb缺乏(gm/l)×体重(kg)×0.24+储存铁mg}。对照组每位患者口服硫酸亚铁200mg,每日3次,疗程4周。孕妇在接受口服和注射铁治疗后4周和8周进行随访。在随访期间监测不良反应,观察临床和实验室反应以及血红蛋白百分比。结果:注射组75例,口服组75例。治疗8周后,注射组Hb水平(11.49±0.39)显著高于口服组(10.39±0.75)。注射组无明显副作用,仅有2例主诉,其中1例主诉上腹痛,1例主诉心动过速,口服组主诉恶心呕吐、上腹痛、便秘、过敏反应分别占42.0%、39.3%、35.7%和3.6%。结论:蔗糖铁复合物治疗缺铁性贫血安全有效。关键词:妊娠期缺铁性贫血,注射用铁,口服铁。孟加拉国妇产科杂志,2018;第33卷(1):40-44
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Bangladesh Journal of Obstetrics and Gynecology
Bangladesh Journal of Obstetrics and Gynecology Medicine-Obstetrics and Gynecology
CiteScore
0.20
自引率
0.00%
发文量
16
期刊介绍: Bangladesh Journals OnLine (BanglaJOL) is a service to provide access to Bangladesh published research, and increase worldwide knowledge of indigenous scholarship
期刊最新文献
A Comparative Study on Feto-Maternal Outcome of GDM Treated by Either Insulin or Metformin Abstract Vol.32(2) Society News Vol.32(2) Expectant Management of Severe Pre-eclampsia remote from term: Maternal and Perinatal outcome Risk Factors and Outcome of Preterm Labour in Tertiary Health Centre
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1